Capital Markets

Company Overview of Tekla Life Sciences Investors

Company Overview

Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries, and in agriculture and environmental management industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as market position for services or products, experience of b...

Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries, and in agriculture and environmental management industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as market position for services or products, experience of business management, technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotech Index and the S&P 500 Index. It was formerly known as H&Q Life Sciences Investors fund. Tekla Life Sciences Investors was formed on February 20, 1992 and is domiciled in the United States.

Tekla Life Sciences Investors Key Developments

On May 15, 2015, Tekla Life Sciences Investors declared a stock distribution of $0.54 per share. The record date for the stock distribution is May 27, 2015 and the payable date is June 30, 2015. The Fund will trade ex-distribution on May 22, 2015.

Tekla Life Sciences Investors, Annual General Meeting, Jun 04, 2015

Apr 20 15

Tekla Life Sciences Investors, Annual General Meeting, Jun 04, 2015., at 08:30 US Eastern Standard Time. Location: Downtown Harvard Club of Boston. Agenda: To propose the election of trustees of fund; to consider the ratification or rejection of the selection of Deloitte & Touche LLP as the independent registered public accountants of fund for the fiscal year ending September 30, 2015; and to consider the transaction of such other business as may properly come before the annual meeting and any adjournment(s) or postponement(s) thereof.

Tekla Life Sciences Investors Declares a Stock Distribution, Payable on March 31, 2015

Feb 20 15

On February 20, 2015, Tekla Life Sciences Investors declared a stock distribution of $0.50 per share. The record date for the stock distribution is March 2, 2015 and the payable date is March 31, 2015. The Fund will trade ex-distribution on February 26, 2015.

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.